[1]王　麟,陈惠新,李小燕.慢性心力衰竭患者血清TRPC1,sFRP5和NT-proBNP水平与心功能及疾病严重程度的临床研究[J].现代检验医学杂志,2021,36(06):6-9.[doi:10.3969/j.issn.1671-7414.2021.06.002]
　WANG Lin,CHEN Hui-xin,LI Xiao-yan.Study on the Relationship between Serum TRPC1, sFRP5 and NT-proBNP Levels and Cardiac Function and Disease Severity in Predicting with Chronic Heart Failure[J].Journal of Modern Laboratory Medicine,2021,36(06):6-9.[doi:10.3969/j.issn.1671-7414.2021.06.002]
点击复制

慢性心力衰竭患者血清TRPC1,sFRP5和NT-proBNP水平与心功能及疾病严重程度的临床研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第36卷
期数:
2021年06期
页码:
6-9
栏目:
论　著
出版日期:
2021-12-15

文章信息/Info

Title:
Study on the Relationship between Serum TRPC1, sFRP5 and NT-proBNP Levels and Cardiac Function and Disease Severity in Predicting with Chronic Heart Failure
文章编号:
1671-7414（2021）06-006-05
作者:
王　麟; 陈惠新; 李小燕
（青海省心脑血管病专科医院急救中心，西宁 810012）
Author(s):
WANG Lin;  CHEN Hui-xin;  LI Xiao-yan
（Emergency Center, Qinghai Province Cardiovascular and Cerebrovascular Diseases Specialist Hospital, Xining 810012, China）
关键词:
慢性心力衰竭; 瞬时受体电位通道1; 分泌型卷曲相关蛋白5; N端前体脑钠肽
分类号:
R541.6；R446.112
DOI:
10.3969/j.issn.1671-7414.2021.06.002
文献标志码:
A
摘要:
目的　探讨血清瞬时受体电位通道1（TRPC1）、分泌型卷曲相关蛋白5（sFRP5）、N端前体脑钠肽（NT-proBNP）与慢性心力衰竭（chronic heart failure, CHF）患者心功能及疾病严重程度的价值。方法　选取2019年6月~2020年6月青海省心脑血管病专科医院收治的217例慢性心力衰竭患者，根据美国纽约心脏病协会（New York heart association, NYHA）心功能分级分为Ⅱ级组74例，Ⅲ级组86例和Ⅳ级组57例，再选取同期健康体检者70例为对照组。比较各组血清TRPC1，sFRP5，NT-proBNP水平、心功能指标，Spearman相关性分析血清TRPC1，sFRP5，NT-proBNP水平与心功能分级、心功能指标的关系。结果　对照组、Ⅱ级组、Ⅲ级组和Ⅳ级组血清TRPC1（10.61%±2.06%，28.03%±4.51%，42.60%±5.70%，54.09%±6.69%），sFRP5（50.31±7.26，61.91±8.40，70.25±9.66，93.09±12.50ng/L），NT-proBNP（54.26±10.60，380.29±36.01，546.52±44.27，801.36±52.09ng/L）水平呈上升趋势，差异均有统计学意义（F=939.480，225.752，4 277.753，均P＜0.05），LVEDD（43.06±4.11，48.20±5.30，54.20±6.16，58.02±6.79mm）依次呈上升趋势，LVEF （67.33%±9.79%，60.19%±8.25%，55.12%±7.24%，43.69%±5.37%）依次呈下降趋势，差异均有统计学意义（F=90.491，99.507，P＜0.05）；TRPC1与心功能分级和LVEDD呈正相关（r=0.966，0.828，均P＜0.05），与LVEF呈负相关（r= - 0.818，P＜0.05）；sFRP5与心功能分级和LVEDD呈正相关（r=0.925，0.802，均P＜0.05），与LVEF呈负相关（r= - 0.787，P＜0.05）；NT-proBNP与心功能分级和LVEDD呈正相关（r=0.966，0.834，均P＜0.05），与LVEF呈负相关（r= - 0.796，P＜0.05）。结论　血清TRPC1，sFRP5和NT-proBNP水平与慢性心力衰竭患者病情严重程度呈正相关，可为临床评估慢性心力衰竭患者病情提供参考。
Abstract:
Objective　To investigate the value of serum transient receptor potential channel 1 (TRPC1), secreted frizzled-related protein 5 (sFRP5) and N-terminal probrain natriuretic peptide (NT-proBNP) in predicting cardiac function and disease severity of chronic heart failure(CHF) . Methods　A total of 217 patients with chronic heart failure admitted to Qinghai Province Cardiovascular and Cerebrovascular Disease Specialist Hospital from June 2019 to June 2020 were selected. According to NYHA cardiac function classification, they were divided into grade II Group (74 cases), grade III group (86 cases) and grade IV group (57 cases), and 70 healthy people were selected as control group. The levels of serum TRPC1, Sfrp5, NT proBNP and cardiac function indexes were compared. Spearman correlation analysis was used to analyze the relationship between the levels of serum TRPC1, Sfrp5, NT proBNP and cardiac function grading and cardiac function indexes. Results　Serum TRPC1, sFRP5 and NT-proBNP levels were 10.61%±2.06%, 50.31±7.26ng/L and 54.26±10.60 ng/L in control group, 28.03%±4.51%, 61.91±8.40ng/L and 380.29±36.01ng/L in grade Ⅱ group, were 42.60%±5.70%, 70.25±9.66ng/L and 546.52±44.27ng/L in grade Ⅲ group, and were 54.09%±6.69%, 93.09±12.50ng/L and 801.36±52.09ng/L in grade Ⅳ group, showing an upward trend (F=939.480, 225.752, 4 277.753, all P<0.05). Meantime, LVEDD of control group, grade Ⅱ group, grade Ⅲ group, and grade Ⅳ group was 43.06±4.11, 48.20±5.30, 54.20±6.16 and 58.02±6.79mm, showing an upward trend. LVEF of control group, grade Ⅱ group, grade Ⅲ group, and grade Ⅳ group was 67.33%±9.79%, 60.19%±8.25%, 55.12%±7.24% and 43.69%±5.37%, showing a downward trend (F=90.491, 99.507, all P<0.05). TRPC1 was positively correlated with cardiac function classification and LVEDD (r=0.966, 0.828, all P<0.05), and negatively correlated with LVEF (r=-0.818, P<0.05). sFRP5 was positively correlated with cardiac function classification and LVEDD (r=0.925, 0.802, all P<0.05), and negatively correlated with LVEF (r=-0.787, P<0.05). NT-proBNP was positively correlated with cardiac function classification and LVEDD (r=0.966, 0.834, all P<0.05), and was negatively correlated with LVEF (r=-0.796, P<0.05). Conclusion　Serum TRPC1, sFRP5 and NT-proBNP levels were positively correlated with the severity of patients with chronic heart failure, which can be used as reliable indicators in the clinical evaluation.

参考文献/References:

[1] 金鑫，郭炳彦，李拥军．分泌型卷曲相关蛋白5 和N 末端B 型利钠肽原与慢性心力衰竭的相关性研究[J]. 河北医科大学学报,2017,38(12):1365-1368, 1372.JIN Xin,GUO Binyan,LI Yongjun. Correlative analysisbetween changes of secreted frizzled-related protein 5and N-terminal B-type natriuretic peptide in patientswith chronic heart failure [J]. Journal of Hebei MedicalUniversity, 2017, 38(12):1365-1368,1372.
[2] 王婷，于远望．心力衰竭相关信号通路研究进展[J].新乡医学院学报, 2019, 36(10):986-989.WANG Ting,YU Yuanwang. Research progress ofheart failure related signaling pathways[J]. Journal ofXinxiang Medical University, 2019, 36(10):986-989.
[3] 陈俊冲, 吴小燕, 林文盛. 心力衰竭患者血清TRPC1水平及其与心功能和预后的关系研究[J]. 重庆医学,2020,49(2):256-259.CHEN Junchong,WU Xiaoyan, LIN Wensheng. Studyon the TRPC1 level in patients with heart failure andits relationship with cardiac function and prognosis[J].Chongqing Medicine, 2020,49(2):256-259.
[4] DEBSKA-KOZLOWSKA A, KSIAZCZYK M,WARCHOL I, et al. Clinical usefulness of N-terminalprohormone of brain natriuretic peptide and highsensitivity troponin T in patients with heart failureundergoing cardiac resynchronization therapy[J].Current Pharmaceutical Design, 2019, 25(14): 1671-1678.
[5] 李金根，徐浩．慢性心力衰竭中西医结合诊疗专家共识[J]. 中国中西医结合杂志, 2016, 36(2):142-145.LI Jingen, XU Hao. Expert consensus on diagnosisand treatment of chronic heart failure with integratedtraditional Chinese and Western Medicine [J]. ChineseJournal of Integrated Traditional and Western Medicine,2016, 36(2):142-145.
[6] BISOC A, CIURESCU D, R?DOI M, et al. Elevationsin high-sensitive cardiac troponin T and N-terminalprohormone brain natriuretic peptide levels in the serumcan predict the development of Anthracycline-Inducedcardiomyopathy[J]. American Journal of Therapeutics,2020, 27(2): e142-e150.
[7] 邓荣花, 韩清华. 血浆脑钠肽与慢性心力衰竭严重程度的相关性分析[J]. 中西医结合心脑血管病杂志,2016, 14(6):618-620.DENG Ronghua，HAN Qinghua. Correlation betweenplasma brain natriuretic peptide and severity of chronicheart failure[J]. Chinese Journal of Integrative Medicineon Cardio/Cerebrovascular Disease, 2016, 14(6):618-620.
[8] KOTECHA D. Letter: Conflicting and unresolved issueof the prognostic value of atrial fibrillation for chronicheart failure patients - response[J]. International Journalof Cardiology, 2016, 214(23): 516-517.
[9] COSTACOU T, SAENGER A K, ORCHARD T J.High-sensitivity cardiac troponin-T and N-terminalprohormone of B-type natriuretic peptide in relation tocardiovascular outcomes in type 1 diabetes[J]. DiabetesCare, 2020, 43(9): 2199-2207.
[10] 李君，冯高科，蒋学俊．SFRP5 对心血管疾病的保护作用[J]. 河北医学,2019,25(5):859-862.LI Jun, FENG Gaoke,JIANG Xuejun. Protectiveeffect of SFRP5 on cardiovascular disease[J]. HebeiMedicine,2019,25(5) :859-862.
[11] 李元国, 崔文贤, 徐晓蓉, 等. 血清Adropin、sFRP5水平与急性心力衰竭患者预后的相关性分析[J]. 标记免疫分析与临床, 2018, 25(12):1789-1792.LI Yuanguo, CUI Wenxian, XU Xiaorong,et al. Thecorrelation between serum adropin and sFRP5 levelsand the prognosis in patients with acute heart failure [J].Labeled Immunoassays and Clinical Medicine, 2018,25(12):1789-1792.
[12] 杨志, 张骥, 唐立萍. 糖尿病肾病患者血浆中VCAM-1, MIF, SFRP-5 含量与肾功能损害的相关性研究[J].海南医学院学报, 2016,25(14):262-265.YANG Zhi,ZHANG Ji,TANG Liping. Correlationbetween VCAM-1, MIF and SFRP-5 content inplasma and renal impairment in patients with diabeticnephropathy[J]. Journal of Hainan Medical University,2016,25(14):262-265.
[13] 崔贞, 刘文. 慢性心力衰竭患者呋塞米治疗对血清NT-proBNP 水平的影响[J]. 现代检验医学杂志,2019,34(3):144-147.CUI Zhen,LIU Wen. Effects of furosemide inpatients with chronic heart failure on serum NTproBNP[J]. Journal of Modern LaboratoryMedicine,2019,34(3):144-147.
[14] CHEN Lili, ZHAO Xiaolong, LIANG Guangjun,et al. Recombinant SFRP5 protein significantlyalleviated intrahepatic inflammation of nonalcoholicsteatohepatitis[J]. Nutrition & Metabolism, 2017, 14(1): 56.
[15] 杜坤, 张梦情, 邓琳, 等. 心力衰竭患者血清NTproBNP和sST2 水平变化及临床意义[J]. 国际检验医学杂志, 2019, 40(1):43-47.DU Kun, ZHANG Mengqing, DENG Lin, et al. Clinicalsignificance of serum NT-proBNP and soluble ST2changes in patients with heart failure [J]. InternationalJournal of Laboratory Medicine, 2019, 40(1):43-47.
[16] CHEN Jieruo, WANG Qing, WU We i , e t a l .Comparison of prognostic values of high-sensitivitycardiac troponin T and N-terminal prohormone brainnatriuretic peptide to assess mortality in elderlyinpatients[J]. Clinical Interventions in Aging, 2019, 14:81-90.
[17] 杨荣培, 刘增长. 槲皮素通过调节SIRT1/NF-κB 通路抑制压力超负荷大鼠左心室肥厚[J]. 重庆医科大学学报, 2020, 45(4):429-435.YANG Rongpei, LIU Zengzhang. Quercetin inhibitsleft ventricular hypertrophy in pressure-overload rats byregulating the SIRT1/NF-κB pathway [J]. Journal ofChongqing Medical University, 2020, 45(4):429-435.
[18] 周依蒙, 郑鹏翔, 陈德, 等. 冠心病合并心力衰竭患者血清Cat S, Periostin, NT-proBNP 水平与心功能指标、炎症因子的关系研究[J]. 国际检验医学杂志,2021,42(3): 270-273,277.ZHOU Yimeng, ZHENG Pengxiang, CHEN De,et al. Study on the relationship between serum CatS,Periostin,NT-proBNP levels in patients with coronaryheart disease complicated with heart failure and itscorrelation with cardiac function indexes,inflammatoryfactors[J]. International Journal of LaboratoryMedicine, 2021,42(3): 270-273,277.
[19] 季一楠, 杨丽霞, 刘蓓, 等.TRPC, ORAI1 和NCX三种钙调控蛋白在血管平滑肌细胞与血管内皮细胞中表达的差异[J]. 昆明医科大学学报, 2019,40(2):13-17.JI Yinan,YANG Lixia,LIU Bei, et al. Differentialexpression of three calcium-regulated proteins,TRPC,ORAI1 and NCX in vascular smooth musclecells and vascular endothelial cells [J]. Journal ofKunming Medical University, 2019, 40(2):13-17.
[20] 王腊梅, 钟华, 唐娜, 等. 钙离子信号蛋白TRPC1及Orai1 参与了HUVEC 经SOC 和ROC 介导的钙内流和NO 生成[J]. 中国动脉硬化杂志,2017,25(12):1189-1195.WANG Lamei,ZHONG Hua,TANG Na,et al. Calciumsignaling proteins TRPC1 and Orai1 participate in Ca2+entry and NO generation mediated by SOC and ROCin human umbilical vein endothelial cell [J]. ChineseJournal of Arteriosclerosis, 2017, 25(12):1189-1195.
[21] KADOGLOU N, KASSIMIS G, PATSOURAKOS N,et al. Omentin-1 and vaspin serum levels in patientswith pre-clinical carotid atherosclerosis and the effectof statin therapy on them[J]. Cytokine, 2021, 138(1):155364.

相似文献/References:

[1]李德璇,王玉明,杨红玲,等.亲环素A与慢性心力衰竭相关性的研究[J].现代检验医学杂志,2015,30(01):31.[doi:10.3969/j.issn.1671-7414.2015.01.009]
　LI De-xuan,WANG Yu-ming,YANG Hong-ling,et al.Study on the Relationship between Cyclophilin A and Chronic HeartFailure[J].Journal of Modern Laboratory Medicine,2015,30(06):31.[doi:10.3969/j.issn.1671-7414.2015.01.009]
[2]崔 贞,刘 文.慢性心力衰竭患者呋塞米治疗对血清NT-proBNP水平的影响[J].现代检验医学杂志,2019,34(03):144.[doi:10.3969/j.issn.1671-7414.2019.03.037]
　CUI Zhen,LIU Wen.Effects of Furosemide in Patientswith Chronic Heart Failure on Serum NT-proBNP[J].Journal of Modern Laboratory Medicine,2019,34(06):144.[doi:10.3969/j.issn.1671-7414.2019.03.037]
[3]易福凌,陈伟芝,王　禺.慢性心力衰竭患者血清 Mb，cTnI，IL-8 和 hs-CRP 水平表达与心功能分级的相关性研究[J].现代检验医学杂志,2021,36(03):58.[doi:10.3969/j.issn.1671-7414.2021.03.013]
　YI Fu-ling,CHEN Wei-zhi,WANG Yu.Correlation between the Expression of Serum MB, cTnI, IL-8, hs-CRP andCardiac Function in Patients with Chronic Heart Failure[J].Journal of Modern Laboratory Medicine,2021,36(06):58.[doi:10.3969/j.issn.1671-7414.2021.03.013]
[4]张卫东,乔明刚.老年心衰并发心律失常患者血清Ang-2，CysC水平及hs-CRP/PAB比值对临床预后评估的价值研究[J].现代检验医学杂志,2021,36(06):128.[doi:10.3969/j.issn.1671-7414.2021.06.027]
　ZHANG Wei-dong,QIAO Ming-gang.Value of Serum Ang-2, Cys C and Hs-CRP/PAB Ratio in the Evaluation of Clinical Prognosis in Elderly Patients with Heart Failure Complicated by Arrhythmia[J].Journal of Modern Laboratory Medicine,2021,36(06):128.[doi:10.3969/j.issn.1671-7414.2021.06.027]
[5]王新庄,孟建涛.慢性心力衰竭患者血清 lncRNA MALAT1的表达水平及其临床意义[J].现代检验医学杂志,2022,37(01):141.[doi:10.3969/j.issn.1671-7414.2022.01.028]
　WANG Xin-zhuang,MENG Jian-tao.Expression of lncRNA MALAT1 in Peripheral Blood of Patients with Chronic Heart Failure and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2022,37(06):141.[doi:10.3969/j.issn.1671-7414.2022.01.028]
[6]陈　伟,侯湘岭.老年慢性心力衰竭患者血清人类母系表达基因3的水平与预后的相关性研究[J].现代检验医学杂志,2022,37(03):26.[doi:10.3969/j.issn.1671-7414.2022.03.006]
　CHEN Wei,HOU Xiang-ling.Study on the Correlation between Serum Human Maternally Expressed Gene 3 Levels and Prognosis in Elderly Patients with Chronic Heart Failure[J].Journal of Modern Laboratory Medicine,2022,37(06):26.[doi:10.3969/j.issn.1671-7414.2022.03.006]
[7]李岗峰,李刘文,刘　璐.慢性心力衰竭患者血清内源性Apela，NT-proBNP及CysC水平与并发肾功能不全的相关性分析[J].现代检验医学杂志,2022,37(03):167.[doi:10.3969/j.issn.1671-7414.2022.03.035]
　LI Gang-feng,LI Liu-wen,LIU Lu.Correlation Analysis of Serum Endogenous Apela, NT-proBNP, Cys C Levels and Renal Insufficiency in Patients with Chronic Heart Failure[J].Journal of Modern Laboratory Medicine,2022,37(06):167.[doi:10.3969/j.issn.1671-7414.2022.03.035]
[8]杨 婷a,赵茜茜,褚 杰a,等.慢性心力衰竭患者血清MCP-3，NRG-1β 和CF6 水平表达与疾病严重程度的相关性研究[J].现代检验医学杂志,2022,37(05):139.[doi:10.3969/j.issn.1671-7414.2022.05.027]
　YANG Tinga,ZHAO Qian-qian,CHU Jiea,et al.Study on the Correlation between the Expression of Serum MCP-3, NRG-1β and CF6 Levels in Patients with Chronic Heart Failure and the Severity of the Disease[J].Journal of Modern Laboratory Medicine,2022,37(06):139.[doi:10.3969/j.issn.1671-7414.2022.05.027]
[9]徐锦华a,王慧娟,励 国a,等.老年慢性心力衰竭患者血清SCD-1 和sVEGFR-2 表达水平及其与预后的评估价值研究[J].现代检验医学杂志,2023,38(04):191.[doi:10.3969/j.issn.1671-7414.2023.04.035]
　XU Jinhuaa,WANG Huijuan,LI Guoa,et al.Study on the Expression Level of Serum SCD-1 and sVEGFR-2 in Elderly Patients with Chronic Heart Failure and Its Prognostic Value[J].Journal of Modern Laboratory Medicine,2023,38(06):191.[doi:10.3969/j.issn.1671-7414.2023.04.035]

备注/Memo

备注/Memo:
基金项目：青海省科学技术项目，编号：9632020J0489。作者简介：王麟（1983-）,男，本科，主治医师，主要研究方向：心血管病研究及诊疗，E-mail：mingliangy1@qq.com。
更新日期/Last Update: 1900-01-01